Last reviewed · How we verify
Conventional antipsychotics
At a glance
| Generic name | Conventional antipsychotics |
|---|---|
| Also known as | conventional antipsychotic |
| Sponsor | Taipei Veterans General Hospital, Taiwan |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of SC-ICBT for Adults With OCD：A Three-Arm Randomized Controlled Trial (NA)
- Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and (NA)
- The Sub-Sero Study (PHASE2)
- Study of Efficacy and Safety of WELT-ED for Eating Disorder (WCTP-ED-B-01) (NA)
- The Efficacy of Probiotics for the Treatment of Alcohol Use Disorder Among Adult Males (NA)
- 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression (PHASE2)
- Comparative Effectiveness Study for Bipolar Disorder (PHASE4)
- Alcoholism and Schizophrenia: Effects of Clozapine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Conventional antipsychotics CI brief — competitive landscape report
- Conventional antipsychotics updates RSS · CI watch RSS
- Taipei Veterans General Hospital, Taiwan portfolio CI